Business
Lifeward’s ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers
Aetna joins Humana and United Healthcare in providing Medicare Advantage coverage for beneficiaries who meet medical necessity criteria for the ReWalk Personal Exoskeleton Together, these three national Medicare Advantage insurers represent approximately 16 million beneficiaries across the United States HUDSON, Mass. and YOKNEAM ILLIT, Israel, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology designed to
About this update from Humana Inc.
[{"type":"image","alt":"Lifeward Ltd.","displaySize":"","headline":null,"caption":"Lifeward Ltd.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":214,"url":"https://media.zenfs.com/en/globenewswire.com/650bbdd4116421044d82c00fb4f6ebe6"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/wsdrGKJN7fPKThSBzlEhlA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTMwMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/650bbdd4116421044d82c00fb4f6ebe6","width":300,"height":214}},"lazy":false},{"type":"text","content":"Aetna joins Humana and United Healthcare in providing Medicare Advantage coverage for beneficiaries who meet medical necessity criteria for the ReWalk Personal Exoskeleton","length":171,"tagName":"p"},{"type":"text","content":"Together, these three national Medicare Advantage insurers represent approximately 16 million beneficiaries across the United States ","length":132,"tagName":"p"},{"type":"text","content":"HUDSON, Mass. and YOKNEAM ILLIT, Israel, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology designed to transform the lives of people with physical limitations or disabilities, today announced that Aetna has issued a prior authorization for a Medicare Advantage beneficiary to obtain the ReWalk Personal Exoskeleton, recognizing the device as medically necessary for a qualifying individual living with spinal cord injury. With Aetna's decision, coverage for the ReWalk Personal Exoskeleton now spans three of the largest Medicare Advantage insurers, as UnitedHealthcare and Humana have also issued prior authorizations for qualified beneficiaries.","length":744,"tagName":"p"},{"type":"text","content":""Aetna's decision represents meaningful progress in expanding access to evidence-based advanced rehabilitation technology," said Mark Grant, CEO of Lifeward. "As leading Medicare Advantage insurers independently review the clinical evidence and reach consistent medical necessity determinations, it reinforces that exoskeleton-assisted walking serves as an appropriate therapeutic intervention for qualified individuals living with spinal cord injury."","length":476,"tagName":"p"},{"type":"text","content":"The ReWalk Personal Exoskeleton System is an FDA-approved technology designed to enable individuals with...